The Solubility Company granted another US patent for our breakthrough SPA™ technology!
We are delighted to attend and present a poster at PharmSci360 this year both in person and virtually.
PRESS RELEASE Helsinki, Finland – The Solubility Company, an innovative preclinical CRO company, has appointed Jussi Hacklin as its Digital Business Advisor. The role will involve working closely with The Solubility Company to expand the ways pharma companies benefit from its proprietary SPATM drug property data in fast-tracking their drugs to the market. The Solubility […]
We are delighted to attend and present at @APS_PharmSci
The Solubility Company and the Research Center Pharmaceutical Engineering join forces in inhalation product R&D Helsinki, Graz – July 12, 2021 – The Austrian Research Center Pharmaceutical Engineering, a global leader for advanced formulation and a pioneer in product optimisation of inhalative medicines, and The Solubility Company, a trusted pre-clinical CRO based in Finland, report […]
The Solubility Company Oy, releases first poster preview video, based on the work of Dr Jernej Štukelj. The poster presentation can be viewed here: ‘Direct Measurement of Amorphous Solubility’ The Poster was originally presented at PharmSci360, Washington DC in Nov 2019. This poster also became the basis for the peer reviewed publication ‘Direct Measurement of Amorphous […]
The Solubility Company Oy, a leading contract research laboratory located in Helsinki, Finland announced today that it has become a member of Scientist.com’s VIP Program. Only laboratories that achieve the highest customer satisfaction rating and that commit to maintaining superior customer service are invited to join the program. Scientist.com blends the safety and security of […]
Solubility And Stability Challenges In Drug Development Finnish Physical Pharmacy Symposium 25th March 2021 At The Solubility Company we are really excited to both sponsor and present at this event, amongst the speakers are some of the worlds thought leaders in the field of ‘Solubility and stability challenges in drug development’ Due to the current […]